Search research articles
Contact Us
Filters
Showing results (191-200 of 206) with videos related to
Page
of 21
Sort By:
Clinical Immunology and Immunopathology
|
July 1, 1987
In vitro effects of thymosin and lithium on lymphoproliferative responses of normal donors and HIV seropositive male homosexuals with AIDS-related complex
M B Sztein, G L Simon, D M Parenti, et al.
Lancet (London, England)
|
June 6, 1987
Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex
W A Carter, D R Strayer, I Brodsky, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 26, 1998
Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury
F Galbiati, D Volonte, O Gil, et al.
Physiological Research
|
February 26, 2014
Opioid-receptor (OR) signaling cascades in rat cerebral cortex and model cell lines: the role of plasma membrane structure
H Ujčíková, J Brejchová, M Vošahlíková, et al.
Journal of Biological Response Modifiers
|
October 1, 1986
Phase I/II trial of thymosin fraction 5 and thymosin alpha one in HTLV-III seropositive subjects
R S Schulof, G L Simon, M B Sztein, et al.
The Journal of Infectious Diseases
|
September 1, 1992
Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis
M M Reddy, M H Grieco, G F McKinley, et al.
Arzneimittel-Forschung
|
October 1, 1986
Treatment of HTLV-III/LAV-infected patients with D-penicillamine
R S Schulof, R G Scheib, D M Parenti, et al.
Blood
|
May 1, 1995
Randomized study of didanosine monotherapy and combination therapy with zidovudine in hemophilic and nonhemophilic subjects with asymptomatic human immunodeficiency virus-1 infection. AIDS Clinical Trial Groups
M V Ragni, D A Amato, M L LoFaro, et al.
Atherosclerosis
|
September 8, 2015
HIV infection induces structural and functional changes in high density lipoproteins
Marc O Siegel, Alison G Borkowska, Larisa Dubrovsky, et al.
AIDS (London, England)
|
September 13, 2000
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II)
J J Eron, R L Murphy, D Peterson, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 206) with videos related to
Sort By:
Page
of 21
Clinical Immunology and Immunopathology
|
July 1, 1987
In vitro effects of thymosin and lithium on lymphoproliferative responses of normal donors and HIV seropositive male homosexuals with AIDS-related complex
M B Sztein, G L Simon, D M Parenti, et al.
Lancet (London, England)
|
June 6, 1987
Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex
W A Carter, D R Strayer, I Brodsky, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 26, 1998
Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury
F Galbiati, D Volonte, O Gil, et al.
Physiological Research
|
February 26, 2014
Opioid-receptor (OR) signaling cascades in rat cerebral cortex and model cell lines: the role of plasma membrane structure
H Ujčíková, J Brejchová, M Vošahlíková, et al.
Journal of Biological Response Modifiers
|
October 1, 1986
Phase I/II trial of thymosin fraction 5 and thymosin alpha one in HTLV-III seropositive subjects
R S Schulof, G L Simon, M B Sztein, et al.
The Journal of Infectious Diseases
|
September 1, 1992
Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis
M M Reddy, M H Grieco, G F McKinley, et al.
Arzneimittel-Forschung
|
October 1, 1986
Treatment of HTLV-III/LAV-infected patients with D-penicillamine
R S Schulof, R G Scheib, D M Parenti, et al.
Blood
|
May 1, 1995
Randomized study of didanosine monotherapy and combination therapy with zidovudine in hemophilic and nonhemophilic subjects with asymptomatic human immunodeficiency virus-1 infection. AIDS Clinical Trial Groups
M V Ragni, D A Amato, M L LoFaro, et al.
Atherosclerosis
|
September 8, 2015
HIV infection induces structural and functional changes in high density lipoproteins
Marc O Siegel, Alison G Borkowska, Larisa Dubrovsky, et al.
AIDS (London, England)
|
September 13, 2000
A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II)
J J Eron, R L Murphy, D Peterson, et al.
Page
of 21